Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
This study has been completed.
First Posted: May 24, 2011
Last Update Posted: August 29, 2016
Information provided by (Responsible Party):